Home > G. Tumoral pathology > Liquid biopsy > Circulating cell-free nucleic acids > KRAS study in circulating tumor DNA
KRAS study in circulating tumor DNA
Sunday 2 November 2014
References
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte P, Robert B, Del Rio M, Lamy PJ, Bibeau F, Nouaille M, Loriot V, Jarrousse AS, Molina F, Mathonnet M, Pezet D, Ychou M. Nat Med. 2014 Apr;20(4):430-5. doi : 10.1038/nm.3511 PMID: 24658074